Therapeutic Areas Infectious Diseases

Infectious Diseases

Infectious Disease research is a large and complex area that is often further complicated by the inclusion of critically ill patient populations that are immunocompromised. CTI team members have contributed to the development programs of several infectious disease agents on the market today including acyclovir, amphotericin B, antimicrobials, ganciclovir, immunoglobulins, simeprevir, and valganciclovir. We are committed to pushing new and innovative therapies through clinical development, and we specialize in hospitalized, complex, and critically ill patient populations.

Sibylle Lawson, MS
Associate Director, Clinical Project Management
Sibylle has over 30 years of industry experience, which started with working as a biological research assistant for an institute specializing in infectious disease. Her experience at CTI includes monitoring and project management positions in both the US and Europe.


Some of our adult and pediatric experience includes:

Specific Areas

  • Adenovirus
  • BK/Polyomavirus
  • Coronavirus / COVID-19
  • Cytomegalovirus (CMV)
  • Fungal infections
    • Aspergillosis
    • Cryptococcus
    • Histoplasmosis
  • Hepatitis B virus (HBV)
  • Hepatitis C virus (HCV)
  • Hepatitis D virus (HDV)
  • Herpes simplex virus (HSV)
  • Human Papillomavirus (HPV)
  • Meningitis

Immunocompromised Populations

  • Hematopoietic stem cell transplantation (HSCT)
  • Human immunodeficiency virus (HIV)
  • Solid organ transplant (heart, kidney, liver, and pancreas)
  • Oncology

We offer our sponsors:

Request Information

Icon Contact Small Retina

CTI is ready to help with your next drug development project

Contact Us